← Back to headlines
Regeneron Receives Approval for Every 20-Week Dosing of Eylea HD
Pharmaceutical company Regeneron has gained approval for an extended 20-week dosing regimen for its drug Eylea HD.
2 Apr, 17:27 — 2 Apr, 17:27
Sources
Showing 1 of 1 sources
Related Stories
Philippines Forecasts 'Extreme Caution' Heat Indices on April 3
just now
Ghana Health Ministry Announces Nationwide Recruitment of Professionals
13m ago
Ghanaian Doctor Laments Brother's Hit-and-Run Death, Citing Emergency Care Gaps
13m ago
Over 3,000 Portuguese Doctors Opt Against Specialization, Leaving Vacancies Unfilled
17m ago